Charles D. “Chuck” Henderson is the Chief Executive Officer of the American Diabetes Association^® (ADA).

Chuck joined the ADA in January 2020 after spending 24-plus years in for-profit sectors and volunteering in the non-profit sector. Philanthropy and Sales/Fundraising are threaded through the fabric of his DNA. Chuck comes to the ADA from Champion Life Safety Solutions where he was CEO and President. Before that, he was a Field Sales Executive running multi-billion-dollar territories across the country for Dell Healthcare, Common ground Marketing (including executing special events in the field), and Viacom. His professional skill set and success, coupled with his passion and desire to give back, make this a perfect time to lead a non-profit organization. He is passionate about spending the balance of his career in a space that will make a significant impact on the lives of millions across the country.

Chuck is skilled in building trusted and collegial working relationships, relationship selling/fundraising, driving productivity, leading, and supporting change-management initiatives. He has deep experience developing best-of-breed, solution-selling leaders who think as strategic business partners, with a culture of winning as a team and over-delivering results.

A native Texan, Chuck has a strong commitment to his family, community, and church. An avid golfer, Chuck is also involved with his alma mater, Texas A&M where he serves on boards and leverages his professional skills to raise money for the school in different capacities. When he is not working on fundraising for A&M causes, he is working on raising capital funds for his church, where he serves on the Board of Trustees. Chuck is married to his beautiful wife Courtney, and together they have a bright teenage daughter, Charlie.

Robert A. Gabbay, MD, PhD, FACP, is the Chief Scientific and Medical Officer for the American Diabetes Association (ADA), the global authority on diabetes. Dr. Gabbay leads the ADA’s efforts to drive discovery within the world of diabetes research, care and prevention.

Previously, Dr. Gabbay served as the Chief Medical Officer and Senior Vice President at Joslin Diabetes Center, and Associate Professor at Harvard Medical School. At Joslin, he oversaw the clinical care for over 25,000 patients, as well as the education and care programs Joslin delivers nationally and internationally. His research focused on innovative models of diabetes care to improve to enhance diabetes outcomes and improve the lives of people with diabetes. To meet these goals, he has traversed many arenas including an initial career as a basic scientist researcher to development of better patient communication tools, creating the first broad scale diabetes registry, designing and implementing a care management training program, leading Pennsylvania’s statewide implementation of the Patient Centered Medical Home and defining the medical neighborhood and the role of centers of excellence in diabetes and envisioning the digital health as the latest member of the diabetes team. Dr. Gabbay has received funding from the National Institute of Health Diabetes, Digestive and Kidneys Diseases (NIDDK), the Agency for Healthcare Research and Quality (AHRQ), and the Center for Medicare and Medicaid Innovation for his care transformation work.

The reach of his work has been recognized through leadership roles in national and international activities to transform diabetes care. Dr. Gabbay has served as visiting professor, keynote speaker and organizing committees for global meetings of the ADA, International Diabetes Federation, Endocrine Society, and the Diabetes Technology Society. Along with an extensive peer reviewed publication record, his views have appeared in popular press such as the New York Times, CNN, Oprah, the Washington Post and NPR.

Dr. Gabbay completed his B.Sc. Degree at McGill University and his PhD in Biochemistry from the University of Wisconsin where  he published on mechanisms of insulin signaling. He then went on to get his medical degree from the State University of New York at Brooklyn School of Medicine with a residency in Internal Medicine at New York Hospital-Cornell and fellowship in Endocrinology, Diabetes and Metabolism at a joint Joslin-Beth Israel Deaconess-Brigham and Women’s Hospital program at Harvard. Dr. Gabbay was a visiting scientist at MIT and a Professor of Medicine at Pennsylvania State University College of Medicine and founding director of the Penn State Institute of Diabetes and Obesity before his tenure at Joslin.

Charlotte is Chief Financial Officer for the American Diabetes Association. Since 1940, the ADA has been committed to its mission to prevent and cure diabetes and to improve the lives of all people affected by diabetes. 

Charlotte is responsible for all financial processes including cash receipt and payable processing, payroll, investment and financing, financial reporting and analysis, tax and compliance, business planning, budgeting and forecasting, key performance and return on investment measures and internal control monitoring. Additionally, Charlotte manages Information Technology & Services, Administration and Legal Affairs for the ADA.

Charlotte first joined the ADA in 1990 and is a seasoned financial professional with decades of experience in both not-for-profit and public accounting. She has lead several financial teams through business process redesigns, financial system implementations, business planning and budgeting and designing financial measurements.

Prior to joining the American Diabetes Association, Charlotte was a staff accountant at Ronald K. King, CPA, where she was responsible for compilation and tax preparation for several individuals, partnerships and corporations.  Additionally, she was part of the audit assurance team. 

Charlotte holds a degree in Accounting from the University of Wyoming in Laramie, Wyoming.  She is also a Certified Public Accountant.

Lisa Murdock is the Chief Advocacy Officer for the American Diabetes Association. With more than 30 years of government affairs experience, Lisa leads the ADA’s advocacy efforts to ensure people with diabetes have access to adequate and affordable health care, insulin and other medications, healthy food and other prevention programs, and that students with diabetes have medically safe and equal access to education.

Gabrielle DeTora is a dynamic chief marketing officer and organizational change-agent with over 20 years of experience uncovering high-impact opportunities through holistic analysis of market intelligence. For more than 12 years, Ms. DeTora has served as principal for DeTora Consulting, LLC advising leadership teams of over 50 health systems representing over 400 hospitals nationwide. She had led numerous health organizations to success with precise strategic planning, integrated marketing, digital, and public relations efforts driving accelerated growth. 

Earlier in her career, Ms. DeTora served as the vice president of health strategy for a major advertising agency and lead the Marketing & Communications team at St. Joseph’s Healthcare System, Hunterdon Healthcare System, the Cure for Lymphoma Foundation, and the Leukemia & Lymphoma Society. This deep experience gives her a keen understanding of the health care industry, which she uses to deliver highly effective strategic marketing plans for her clients.

Beyond the work Ms. DeTora conducts for her clients, she is also called upon regularly to keynote at national health care conferences, including the Forum for Healthcare Strategists Summits, National HealthCare Roundtable, Society for Healthcare Strategy and Market Development (SHSMD), and the Healthcare Center of Excellence Summits. In addition, Ms. DeTora regularly contributes articles to and is a quoted expert for publications such as HealthLeaders, Healthcare Advertising Review, Healthcare Marketing Report, Healthcare Marketing Advisor, Spectrum, Alert, and MHS. 

As a national leader in health care marketing, Ms. DeTora was published among the nation’s best in the AHA Society of Healthcare Strategy and Market Development book, The Thought Leadership Project: Hospital Marketing.

Ms. DeTora has an MBA from Kennedy-Western University and a Bachelor of Business Administration from the Zicklin School of Business (CUNY).

Passionate about bridging business development with health and wellness, Tiffany Ingram, M.Ed. returns to the ADA with over 13 years of experience in the healthcare sector with demonstrable success in driving results for positive change. Over her career, Tiffany has led enterprise-wide initiatives that leverage her expertise in the areas of sales, fundraising, advocacy, community health education, and health equity platforms to generate revenue; address strategic priorities and operational imperatives through outcome-driven programs and initiatives, and cultivate brand champions to improve organizational reach and impact.

While at the ADA previously, she worked in various capacities such as Director of Strategic Programs and Mission Delivery, Director of Development and Corporate Engagement, and National Director of Type 2 Diabetes Programs Outreach and Evaluation over a five-year span. Her work was widely recognized and resulted in the receipt of several national awards from the ADA for Mission Delivery Excellence, including the Award for “Outstanding Work and Exceptional Commitment to Stop Diabetes in the African American Community”; Mission Appreciation Program (MAP) Award for “Reaching People in the Community”; and Key Markets East “Rookie of the Year” Award.

Prior to joining the ADA, Tiffany worked for Novo Nordisk in health care sales, where she launched new diabetes medications, like VICTOZA®; drove sales for Novo Nordisk’s overall multi-billion insulin analog portfolio; served on the Regional Advisory Panel for the region; and led hospital formulary wins for insulin therapies within the hospital setting. Additionally, Tiffany collaborated frequently with the company’s office of government affairs to advance efforts to promote federal support and funding for policies and programs, including the National Changing Diabetes Prevention Program and the Take Action School Challenge Diabetes Program, as well as Novo Nordisk’s bi-annual Advocacy Day program. She also represented Novo Nordisk as a proud volunteer with numerous diabetes-focused non-profits, such as the ADA, where she was a Corporate Co-Chair for the Step Out Walk to Stop Diabetes.

Tiffany received her undergraduate degree in Marketing from Iowa State University and her Master of Education from Johns Hopkins University. She is a native of Houston, Texas. She and her husband, Jason, are the proud parents of two sons—Jason Jr. and Jameson.

She is very excited to return to the ADA where she is looking forward to collaborating across the ADA for win-win solutions.

Sean C.E. McDonough is Vice President and General Counsel of the American Diabetes Association (ADA), the nation's largest voluntary health organization and a global authority on diabetes. Since 1940, the ADA has been committed to its mission to prevent and cure diabetes and to improve the lives of all people affected by diabetes.

Mr. McDonough leads the ADA’s Legal Affairs Division overseeing the ADA’s contracts, transactions, intellectual property portfolio, risk management, compliance and litigation, all with a goal of helping the ADA to achieve its mission while employing best practices and being a great business steward to all who support the ADA and the diabetes community. Mr. McDonough also provides legal, compliance and parliamentarian guidance to the ADA’s Board of Directors, Bylaws Committees, Task Forces and ADA’s Research Foundation.

Mr. McDonough joined the ADA in 2016 after 25 years in private practice providing counsel to for profit and nonprofit businesses and governmental entities on governance, transactions, acquisitions, employment matters, regulatory compliance, intellectual property and complex commercial litigation. He is licensed in Virginia and the District of Columbia.  Mr. McDonough has successfully served as first chair lead in over 100 jury and bench trials in Federal and State courts in Virginia, Maryland, and the District of Columbia and briefed and argued dozens of appeals in the highest courts in those jurisdictions.

Prior to practicing law, Mr. McDonough worked for Price Waterhouse in its Audit division focusing on technology, manufacturing, nonprofit and financial institutions and serving on a fraud auditing team.

Mr. McDonough earned his Bachelor of Science degree in Commerce with a concentration in Accounting from the McIntire School of Commerce at the University of Virginia and his Juris Doctor from the Marshall-Wythe School of Law at the College of William and Mary. He and his family reside in the Washington, D.C. metropolitan area.